AR

Argentina

4920 clinical trials

Find Trials

Clinical Trials (4920)

Showing 20 of 4,920 trialsScroll for more
NCT05296798Phase 37 sites

A Study to Evaluate the Efficacy and Safety of Giredestrant in Combination With Phesgo (Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf) Versus Phesgo in Participants With Locally Advanced or Metastatic Breast Cancer (heredERA Breast Cancer)

Active Not Recruiting
NCT06291376Phase 35 sites

Study of Ravulizumab in Immunoglobulin A Nephropathy (IgAN)

Active Not Recruiting
NCT03340506Phase 41 site

Dabrafenib and/or Trametinib Rollover Study

Recruiting
NCT04976322Phase 36 sites

A Study to Evaluate the Safety and Tolerability of Dapirolizumab Pegol in Study Participants With Systemic Lupus Erythematosus

Enrolling By Invitation
NCT06864351Not Applicable1 site

Prospective Evaluation of OptiThyDose

Recruiting
NCT05624450Phase 39 sites

Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen

Recruiting
NCT07691970Phase 32 sites

Rollover Study for Participants Who Have Completed a Previous Clinical Study With Anifrolumab (Saphnelo) and Clinically Benefited From Continued Treatment

Recruiting
NCT06796907Phase 14 sites

A Study of Mocertatug Rezetecan in Combination With Anti-cancer Therapies for Advanced Solid Tumors (BEHOLD-2)

Recruiting
NCT06079879Phase 33 sites

A Study of Bomedemstat (IMG-7289/MK-3543) Compared to Best Available Therapy (BAT) in Participants With Essential Thrombocythemia and an Inadequate Response or Intolerance of Hydroxyurea (MK-3543-006)

Active Not Recruiting
NCT03486873Phase 321 sites

Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

Recruiting
NCT06956235Phase 24 sites

Study to Evaluate Tulisokibart for Hidradenitis Suppurativa (MK-7240-012)

Active Not Recruiting
NCT07694427Phase 31 site

Mo-Rez in First- Line (1L) Maintenance Treatment of Non-Homologous Recombination Deficient Ovarian Cancer (Non-HRd OC) [BEHOLD-Ovarian03]

Not Yet Recruiting
NCT06307652Phase 318 sites

Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function

Recruiting

A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology Products

Active Not Recruiting
NCT06588855Phase 32 sites

A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis

Active Not Recruiting
NCT05827081Phase 33 sites

Phase IIIb Study of Ribociclib + ET in Early Breast Cancer

Recruiting
NCT06033833Phase 29 sites

Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study

Terminated
NCT07440225Phase 220 sites

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)

Recruiting
NCT06623422Phase 36 sites

A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)

Recruiting
NCT07680764Phase 23 sites

A Study To Assess the Safety, Tolerability, and Efficacy of Imzokitug in Combination With Pumitamig and Platinum-Doublet Chemotherapy (PDCT) Versus Pumitamig and PDCT as First-line Treatment for Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Recruiting